What is hepatitis?
Hepatitis is an inflammation of the liver that is caused by a variety of infectious viruses and noninfectious agents.1Each strain of the virus can cause liver disease, making an accurate diagnosis critical for disease mitigation and improving patient outcomes.
What is the healthcare burden of hepatitis?
Viral hepatitis is a worldwide public health issue that impacts millions of people. The WHO estimates that 296 million people worldwide are living with hepatitis B, 58 million people worldwide are living with hepatitis C, and 1.5 million people were newly infected with chronic hepatitis B along with1.5 million people were newly infected with chronic hepatitis C.2
The role of diagnostics is key as hepatitis infections can be “silent” making many infected individuals unaware of their diagnosis. Although hepatitis is widespread and highly prevalent, many people worldwide live with hepatitis B or C and do not have accessibility to testing or adequate treatment.1
Due to the high prevalence of hepatitis, World Hepatitis Day is recognized annually on July 28th – on the birthday of Dr. Baruch Blumberg who discovered hepatitis B in 1967, and proceeded to develop the first hepatitis B vaccine.3World Hepatitis Day promotes the need to raise awareness, education, and encourage actions to prevent these infections to support better public health globally.
Hepatitis – Our Diagnostic Offer
A Complete Panel to Address a Complex Clinical Picture
Hepatitis, especially hepatitis B, presents a complex clinical picture. Various markers are necessary for accurate diagnosis and efficient monitoring.
The VIDAS® Hepatitis panel includes 11 automated assays offering a complete solution for the diagnosis and monitoring of Hepatitis A, B, C and E. Used together, they enable clinicians to provide a differential diagnosis for patients presenting with symptoms suggestive of hepatitis.
-
VIDAS® KUBE™
Stackable benchtop automated immunoassay solution
VIDAS® KUBE™ is designed to preserve everything labs appreciate about the VIDAS® Solution combined with advanced technology. VIDAS® KUBE™ is a truly flexible, cost-effective automated immunoassay solution providing fast results in complete confidence.
-
VIDAS® NEPHROCHECK®
Reveal Kidney Stress Early. Drive Better Outcomes.
VIDAS® NEPHROCHECK® measures urinary TIMP-2 & IGFBP-7, specific urinary biomarkers for early risk assessment of moderate to severe Acute Kidney Injury (AKI). The VIDAS® NEPHROCHECK® assay is intended to be used in conjunction with clinical evaluation as an aid in the risk assessment for moderate or severe acute kidney injury (AKI) in acutely ill patients.
-
VIDAS® NT-proBNP 2
Exclusion or Confirmation of Acute Heart Failure
VIDAS® NT-proBNP2 is a useful tool for rapid and clinical assessment and diagnosis of patients with symptoms of suspected heart failure.
High sensitivity and specificity allows initiation of timely, appropriate treatment.
Cost-effective tool adapted to emergency situations.
-
VIDAS® SARS-COV-2
Two immunoassay tests to detect IgM & IgG antibodies
VIDAS® SARS-COV-2 IgM and VIDAS® SARS-COV-2 IgG II automated qualitative assays rapidly detect antibodies to help identify individuals with previous exposure to SARS-CoV-2.
-
VIDAS® TB-IGRA
Reliable and fully automated solution for Tuberculosis (TB) infection detection
Available on the VIDAS® 3 immunoanalyzer, VIDAS® TB-IGRA is a whole-blood test for the diagnosis of Mycobacterium tuberculosis infection. -
VIDAS® TBI (GFAP, UCH-L1)
RULES-OUT Intracranial Lesions for mild Traumatic Brain Injury
Fast all-in-one test kit based on blood brain biomarkers to predict absence of intracranial lesions in mild Traumatic Brain Injury patients and objectively assess the need for a head CT-scan.
-
VIDAS® Thyroid Assays
A Full Panel for the Investigation of Thyroid Diseases
The VIDAS® Thyroid panel includes 8 automated tests to aid clinicians in the diagnosis and treatment monitoring of thyroid disorders.
-
VIDAS® ToRC Panel
Serenity throughout Pregnancy
The VIDAS® ToRC panel included 9 automated tests for the screening and diagnosis of toxoplasmosis, rubella, and cytomegalovirus (CMV) infections.
-
VIDAS® Tumour Markers
Diagnosis and Treatment Monitoring of Various Cancers
The VIDAS® panel of Tumour Markers offers a rapid, automated, precise, and reliable solution to meet your diagnostic needs.
-
VIDAS® B•R•A•H•M•S PCT™
Important Biomarker for Improved Patient Management
Detects procalcitonin, a biomarker that aids in the risk assessment for progression to severe sepsis and septic shock. PCT also aids in decision making on antibiotic therapy for patients with lower respiratory tract infections (LRTI).
-
VILINK®
Optimize Instrument UPTIME to Improve Laboratory Productivity
A secure solution offering remote access, proactive maintenance, and remote updates. VILINK® diagnoses, solves software and instrument issues, and supports your systems to enable laboratory productivity and efficiency improvements.
-
VITEK® 2
Fully integrated Identification and Antimicrobial Susceptibility Testing
VITEK® 2, the leading automated system for routine antimicrobial susceptibility testing, provides efficient workflow, faster AST results. Its fully-integrated ID & AST approach ensures superior performance to rapidly and confidently guide therapy.
-
VITEK® 2 COMPACT
Compact, automated ID/AST instrument
The compact solution for fast, accurate ID/AST testing with expert confidence
-
VITEK® 2 ID & AST Cards
Rapid. Flexible. Efficient.
Providing accurate and reliable identification and antimicrobial susceptibility results for clinically relevant organisms with self-contained, disposable test cards designed for VITEK® 2 automated systems.
-
VITEK® MS
Microbial Identification in Minutes
VITEK® MS provides rapid and robust identification of microorganisms delivering clinicians with actionable results to support informed treatment decisions.
Product availability varies by country. Consult your local bioMérieux representative for availability in your country.
Useful Resources on Hepatitis
Contact Us for Information on Our Solutions for Viral Hepatitis
References
1. World Health Organization. (2022). Hepatitis. Www.who.int.https://www.who.int/health-topics/hepatitis#tab=tab_1
2. WHO. (2021). Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Www.who.int. https://www.who.int/publications/i/item/9789240027077
3. World Hepatitis Day — July 28th | CDC. (2020, July 31). Www.cdc.gov. https://www.cdc.gov/hepatitis/awareness/worldhepday.htm
